The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Rifampicin
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- Acronyms PETE
- 31 Aug 2018 Biomarkers information updated
- 31 Dec 2008 Actual start date (Nov 2008) added as reported by ClinicalTrials.gov.
- 31 Dec 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.